Stocks & Investing
Wed, September 25, 2024
[ 12:00 AM ] - WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 27, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 1, 2024
[ 12:00 AM ] - WOPRAI
Tue, January 2, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 15, 2023
[ 12:00 AM ] - WOPRAI
Tue, November 14, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 11, 2023
[ 12:00 AM ] - WOPRAI
Thu, May 25, 2023
[ 12:00 AM ] - WOPRAI
Mon, March 27, 2023
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
Wed, January 4, 2023
[ 12:00 AM ] - WOPRAI
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 8, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 1, 2022
Tue, August 10, 2021
[ 12:00 AM ] - WOPRAI
Tue, February 16, 2021
Tue, February 2, 2021
[ 12:00 AM ] - WOPRAI
Mon, December 9, 2019
[ 12:00 AM ] - WOPRAI
Fri, December 4, 2015 Yanan Zhu Maintained (BLUE) at Hold with Decreased Target to $2 on, Sep 25th, 2024
Yanan Zhu of Wells Fargo, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $3 to $2 on, Sep 25th, 2024.
Yanan has made no other calls on BLUE in the last 4 months.
There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 3 agree with Yanan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Hold on, Monday, September 16th, 2024
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $4 on, Thursday, August 15th, 2024
- Eric Joseph of "JP Morgan" Downgraded from Buy to Hold on, Thursday, August 15th, 2024
These are the ratings of the 3 analyists that currently disagree with Yanan
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $4 on, Thursday, August 15th, 2024
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $6 on, Thursday, August 15th, 2024
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $3 on, Thursday, August 15th, 2024
